QIAGEN N.V. (QGEN) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:QGEN - NL0015002CX3 - Common Stock
47.22 USD
+0.38 (+0.81%)
47.64 USD
+0.42 (+0.89%)
We assign a fundamental rating of 6 out of 10 to QGEN. QGEN was compared to 58 industry peers in the Life Sciences Tools & Services industry. QGEN scores excellent points on both the profitability and health parts. This is a solid base for a good stock. QGEN has a correct valuation and a medium growth rate. These ratings could make QGEN a good candidate for quality investing.
1. Profitability
1.1 Basic Checks
In the past year QGEN was profitable.
In the past year QGEN had a positive cash flow from operations.
In the past 5 years QGEN has always been profitable.
In the past 5 years QGEN always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of 6.19%, QGEN belongs to the top of the industry, outperforming 82.76% of the companies in the same industry.
QGEN's Return On Equity of 11.11% is amongst the best of the industry. QGEN outperforms 82.76% of its industry peers.
Looking at the Return On Invested Capital, with a value of 7.44%, QGEN is in the better half of the industry, outperforming 79.31% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for QGEN is significantly below the industry average of 13.53%.
The 3 year average ROIC (7.25%) for QGEN is below the current ROIC(7.44%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.19% | ||
| ROE | 11.11% | ||
| ROIC | 7.44% |
ROA(3y)4.59%
ROA(5y)5.65%
ROE(3y)7.84%
ROE(5y)10.58%
ROIC(3y)7.25%
ROIC(5y)7.96%
1.3 Margins
Looking at the Profit Margin, with a value of 19.58%, QGEN belongs to the top of the industry, outperforming 94.83% of the companies in the same industry.
In the last couple of years the Profit Margin of QGEN has declined.
QGEN has a Operating Margin of 27.02%. This is amongst the best in the industry. QGEN outperforms 96.55% of its industry peers.
QGEN's Operating Margin has improved in the last couple of years.
The Gross Margin of QGEN (64.10%) is better than 86.21% of its industry peers.
In the last couple of years the Gross Margin of QGEN has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 27.02% | ||
| PM (TTM) | 19.58% | ||
| GM | 64.1% |
OM growth 3Y-5.04%
OM growth 5Y4.09%
PM growth 3Y-42.96%
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y-0.63%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so QGEN is destroying value.
The number of shares outstanding for QGEN has been reduced compared to 1 year ago.
Compared to 5 years ago, QGEN has less shares outstanding
QGEN has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 3.56 indicates that QGEN is not in any danger for bankruptcy at the moment.
QGEN has a better Altman-Z score (3.56) than 68.97% of its industry peers.
QGEN has a debt to FCF ratio of 4.50. This is a neutral value as QGEN would need 4.50 years to pay back of all of its debts.
QGEN has a Debt to FCF ratio of 4.50. This is in the better half of the industry: QGEN outperforms 72.41% of its industry peers.
QGEN has a Debt/Equity ratio of 0.45. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.45, QGEN is not doing good in the industry: 60.34% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.45 | ||
| Debt/FCF | 4.5 | ||
| Altman-Z | 3.56 |
ROIC/WACC0.95
WACC7.81%
2.3 Liquidity
A Current Ratio of 2.60 indicates that QGEN has no problem at all paying its short term obligations.
The Current ratio of QGEN (2.60) is comparable to the rest of the industry.
A Quick Ratio of 2.30 indicates that QGEN has no problem at all paying its short term obligations.
QGEN has a Quick ratio (2.30) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.6 | ||
| Quick Ratio | 2.3 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 9.62% over the past year.
QGEN shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.40% yearly.
QGEN shows a small growth in Revenue. In the last year, the Revenue has grown by 5.32%.
The Revenue has been growing slightly by 5.32% on average over the past years.
EPS 1Y (TTM)9.62%
EPS 3Y-6.66%
EPS 5Y8.4%
EPS Q2Q%4.04%
Revenue 1Y (TTM)5.32%
Revenue growth 3Y-4.22%
Revenue growth 5Y5.32%
Sales Q2Q%6.09%
3.2 Future
QGEN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.80% yearly.
The Revenue is expected to grow by 7.89% on average over the next years.
EPS Next Y8.55%
EPS Next 2Y8.08%
EPS Next 3Y8.5%
EPS Next 5Y8.8%
Revenue Next Year5.25%
Revenue Next 2Y5.45%
Revenue Next 3Y5.86%
Revenue Next 5Y7.89%
3.3 Evolution
The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 19.92, the valuation of QGEN can be described as rather expensive.
Based on the Price/Earnings ratio, QGEN is valued cheaply inside the industry as 87.93% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of QGEN to the average of the S&P500 Index (25.65), we can say QGEN is valued slightly cheaper.
The Price/Forward Earnings ratio is 18.19, which indicates a rather expensive current valuation of QGEN.
Compared to the rest of the industry, the Price/Forward Earnings ratio of QGEN indicates a rather cheap valuation: QGEN is cheaper than 89.66% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 34.45. QGEN is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.92 | ||
| Fwd PE | 18.19 |
4.2 Price Multiples
QGEN's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. QGEN is cheaper than 91.38% of the companies in the same industry.
86.21% of the companies in the same industry are more expensive than QGEN, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.67 | ||
| EV/EBITDA | 13.8 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates QGEN does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of QGEN may justify a higher PE ratio.
PEG (NY)2.33
PEG (5Y)2.37
EPS Next 2Y8.08%
EPS Next 3Y8.5%
5. Dividend
5.1 Amount
QGEN has a yearly dividend return of 0.55%, which is pretty low.
QGEN's Dividend Yield is rather good when compared to the industry average which is at 0.49. QGEN pays more dividend than 94.83% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.41, QGEN's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.55% |
5.2 History
QGEN is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y8.08%
EPS Next 3Y8.5%
47.22
+0.38 (+0.81%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners89.95%
Inst Owner Change-18.51%
Ins Owners0.44%
Ins Owner ChangeN/A
Market Cap10.24B
Revenue(TTM)2.07B
Net Income(TTM)405.37M
Analysts74.17
Price Target51.67 (9.42%)
Short Float %2.86%
Short Ratio5.25
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.55% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.14%
Min EPS beat(2)-2.4%
Max EPS beat(2)2.11%
EPS beat(4)2
Avg EPS beat(4)0.92%
Min EPS beat(4)-3.85%
Max EPS beat(4)7.8%
EPS beat(8)5
Avg EPS beat(8)1.59%
EPS beat(12)8
Avg EPS beat(12)2.59%
EPS beat(16)12
Avg EPS beat(16)5.18%
Revenue beat(2)0
Avg Revenue beat(2)-0.42%
Min Revenue beat(2)-0.72%
Max Revenue beat(2)-0.12%
Revenue beat(4)1
Avg Revenue beat(4)-0.33%
Min Revenue beat(4)-1.92%
Max Revenue beat(4)1.43%
Revenue beat(8)1
Avg Revenue beat(8)-0.6%
Revenue beat(12)2
Avg Revenue beat(12)-0.64%
Revenue beat(16)6
Avg Revenue beat(16)0.46%
PT rev (1m)-1.37%
PT rev (3m)-1.98%
EPS NQ rev (1m)-1.93%
EPS NQ rev (3m)-1.69%
EPS NY rev (1m)0%
EPS NY rev (3m)0.63%
Revenue NQ rev (1m)-1.91%
Revenue NQ rev (3m)-1.91%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.14%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.92 | ||
| Fwd PE | 18.19 | ||
| P/S | 4.94 | ||
| P/FCF | 21.67 | ||
| P/OCF | 15.57 | ||
| P/B | 2.81 | ||
| P/tB | 12.83 | ||
| EV/EBITDA | 13.8 |
EPS(TTM)2.37
EY5.02%
EPS(NY)2.6
Fwd EY5.5%
FCF(TTM)2.18
FCFY4.61%
OCF(TTM)3.03
OCFY6.42%
SpS9.55
BVpS16.83
TBVpS3.68
PEG (NY)2.33
PEG (5Y)2.37
Graham Number29.96
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.19% | ||
| ROE | 11.11% | ||
| ROCE | 10.03% | ||
| ROIC | 7.44% | ||
| ROICexc | 10.67% | ||
| ROICexgc | 39.98% | ||
| OM | 27.02% | ||
| PM (TTM) | 19.58% | ||
| GM | 64.1% | ||
| FCFM | 22.82% |
ROA(3y)4.59%
ROA(5y)5.65%
ROE(3y)7.84%
ROE(5y)10.58%
ROIC(3y)7.25%
ROIC(5y)7.96%
ROICexc(3y)9.42%
ROICexc(5y)10.13%
ROICexgc(3y)34.6%
ROICexgc(5y)42.77%
ROCE(3y)9.77%
ROCE(5y)10.73%
ROICexgc growth 3Y-31.24%
ROICexgc growth 5Y-2.41%
ROICexc growth 3Y-13.09%
ROICexc growth 5Y6.48%
OM growth 3Y-5.04%
OM growth 5Y4.09%
PM growth 3Y-42.96%
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y-0.63%
F-Score8
Asset Turnover0.32
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.45 | ||
| Debt/FCF | 4.5 | ||
| Debt/EBITDA | 2.17 | ||
| Cap/Depr | 97.52% | ||
| Cap/Sales | 8.94% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 87.76% | ||
| Profit Quality | 116.56% | ||
| Current Ratio | 2.6 | ||
| Quick Ratio | 2.3 | ||
| Altman-Z | 3.56 |
F-Score8
WACC7.81%
ROIC/WACC0.95
Cap/Depr(3y)78.4%
Cap/Depr(5y)95.94%
Cap/Sales(3y)7.97%
Cap/Sales(5y)9.87%
Profit Quality(3y)273.85%
Profit Quality(5y)189.74%
High Growth Momentum
Growth
EPS 1Y (TTM)9.62%
EPS 3Y-6.66%
EPS 5Y8.4%
EPS Q2Q%4.04%
EPS Next Y8.55%
EPS Next 2Y8.08%
EPS Next 3Y8.5%
EPS Next 5Y8.8%
Revenue 1Y (TTM)5.32%
Revenue growth 3Y-4.22%
Revenue growth 5Y5.32%
Sales Q2Q%6.09%
Revenue Next Year5.25%
Revenue Next 2Y5.45%
Revenue Next 3Y5.86%
Revenue Next 5Y7.89%
EBIT growth 1Y18.55%
EBIT growth 3Y-9.05%
EBIT growth 5Y9.63%
EBIT Next Year57.27%
EBIT Next 3Y22.23%
EBIT Next 5Y15.78%
FCF growth 1Y71.67%
FCF growth 3Y5.12%
FCF growth 5Y55.1%
OCF growth 1Y52.1%
OCF growth 3Y1.77%
OCF growth 5Y15.28%
QIAGEN N.V. / QGEN FAQ
Can you provide the ChartMill fundamental rating for QIAGEN N.V.?
ChartMill assigns a fundamental rating of 6 / 10 to QGEN.
What is the valuation status of QIAGEN N.V. (QGEN) stock?
ChartMill assigns a valuation rating of 6 / 10 to QIAGEN N.V. (QGEN). This can be considered as Fairly Valued.
What is the profitability of QGEN stock?
QIAGEN N.V. (QGEN) has a profitability rating of 8 / 10.
What are the PE and PB ratios of QIAGEN N.V. (QGEN) stock?
The Price/Earnings (PE) ratio for QIAGEN N.V. (QGEN) is 19.92 and the Price/Book (PB) ratio is 2.81.